{"disease":{"id":"copd-bronchitis","name":"copd bronchitis"},"drugs":{"marketed":[{"drug_id":"fluticasone-propionate","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cutivate","generic_name":"FLUTICASONE PROPIONATE","company_name":"Teva Pharm","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":64,"revenue":"69.0","mechanism":""},{"drug_id":"formoterol","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foradil","generic_name":"FORMOTEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":56,"revenue":null,"mechanism":"Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"fluticasone","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flonase","generic_name":"fluticasone propionate","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Inhaled/intranasal corticosteroid","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"flixotide","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Flixotide","company_name":"Mundipharma Research Limited","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluticason","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluticason","company_name":"Creighton University","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"theophyllin","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"serevent","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Serevent","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"daxas","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Daxas","company_name":"AstraZeneca","drug_phase":"phase_2","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B, cAMP-specific 3',5'-cyclic phosphodiesterase 4D","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"roflumilast","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Daliresp","generic_name":"ROFLUMILAST","company_name":"Arcutis","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4D","drug_class":"Phosphodiesterase 4 Inhibitor [EPC]","quality_score":63,"revenue":null,"mechanism":"Daliresp works by blocking an enzyme called phosphodiesterase 4, which helps reduce inflammation in the body."},{"drug_id":"aminophyllin","indication_name":"COPD Associated with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT05330637","title":"Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT02789800","title":"Patient-Centred Innovations for Persons With Multimorbidity - Quebec","phase":"NA","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT06921278","title":"Development of the Drug and Alcohol Respiratory Health Test","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":260,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT02742597","title":"Patient-Centred Innovations for Persons With Multimorbidity - Ontario","phase":"NA","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT02099799","title":"The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04631016","title":"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT06571942","title":"Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"National Institute of Respiratory Diseases, Mexico","has_results":false},{"nct_id":"NCT06826560","title":"Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT05507242","title":"Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Asger Sverrild","has_results":false},{"nct_id":"NCT06022627","title":"EFFECT OF PRANAYAMA YOGA ON COPD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Yeditepe University","has_results":false},{"nct_id":"NCT03892694","title":"Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"CSA Medical, Inc.","has_results":false},{"nct_id":"NCT02416102","title":"Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"University of Miami","has_results":true},{"nct_id":"NCT06304207","title":"Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"MGH Institute of Health Professions","has_results":false},{"nct_id":"NCT06891274","title":"Pulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Jingen Xia","has_results":false},{"nct_id":"NCT02154568","title":"Study of Airflow in the Lungs Using Helium MRI","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT03631472","title":"Gala Early Feasibility Study of RheOx","phase":"NA","overall_status":"UNKNOWN","enrollment_count":21,"lead_sponsor_name":"Gala Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03123692","title":"NBMI - Clinical Study on COPD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"EmeraMed","has_results":false},{"nct_id":"NCT03073798","title":"The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT07468617","title":"Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"CSA Medical, Inc.","has_results":false},{"nct_id":"NCT03653104","title":"Melodica Orchestra for Dyspnea: Safety and Feasibility Pilot","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"VA Quality Enhancement Research Intiative","has_results":false},{"nct_id":"NCT03228121","title":"Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Lung Institute","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}